Thus, immunohistochemistry for DNMT3B, which can be performed on the formalin-fixed, paraffin-embedded tissue specimens prepared for routine pathological diagnosis, may be clinically useful for prognostication of stage I seminomas after prospective validation. Here, DNMT3B is linked to seminoma.